van der Weg, K.; Bertschinger, M.; Bacher, U.; Hoffmann, M.; Nilius, H.; Seipel, K.; Pabst, T.
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma. Cancers 2026, 18, 2032.
https://doi.org/10.3390/cancers18132032
AMA Style
van der Weg K, Bertschinger M, Bacher U, Hoffmann M, Nilius H, Seipel K, Pabst T.
Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma. Cancers. 2026; 18(13):2032.
https://doi.org/10.3390/cancers18132032
Chicago/Turabian Style
van der Weg, Katharina, Martina Bertschinger, Ulrike Bacher, Michele Hoffmann, Henning Nilius, Katja Seipel, and Thomas Pabst.
2026. "Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma" Cancers 18, no. 13: 2032.
https://doi.org/10.3390/cancers18132032
APA Style
van der Weg, K., Bertschinger, M., Bacher, U., Hoffmann, M., Nilius, H., Seipel, K., & Pabst, T.
(2026). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma. Cancers, 18(13), 2032.
https://doi.org/10.3390/cancers18132032